| Serial Number | 79444786 |
| Word Mark | KEENOVA |
| Filing Date | Monday, December 15, 2025 |
| Status | 647 - EXAMINERS AMENDMENT - MAILED |
| Status Date | Monday, July 20, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services; medical research in the fields of chemicals and pharmaceuticals; scientific research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; development of pharmaceutical products to specifications of others; research and development of pharmaceutical products for others. |
| Goods and Services | Healthcare management services, namely, providing administrative support services to physicians and healthcare providers who prescribe pharmaceutical preparations; outsourcing services in the nature of arranging service contracts or others in the field of pharmaceuticals; business administration of patient reimbursement programs for pharmaceuticals; business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient |
| Goods and Services | Pharmaceutical products for the treatment of pain management, infectious diseases, central nervous system disorders, namely, epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; pharmaceutical preparations for the treatment of pain management, infectious diseases, central nervous system disorders, namely, epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer · treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; ready-to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities; radio frequency identification tagged pharmaceutical products for the treatment of cardiovascular, central nervous system, infectious, metabolic, respiratory, gastrointestinal, inflammatory, oncologic, and pain related conditions, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, diuretic agents, psychiatries, antivirals, thyroid agents, corticosteroids, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents; pharmaceutical preparations for the treatment of cardiovascular, central nervous system, infectious, metabolic, respiratory, gastrointestinal, inflammatory, oncologic, and pain related conditions; pharmaceutical and medical preparations in connection with critical care, critical testing, maternal health, anesthesia, diseases, kidney disorders, cellulite, skin care, dermatological use, folds, scars, and body contouring and for rejuvenating to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities and in doctor's offices; pharmaceutical preparations, namely, analgesics and pain management preparations, preparations for the treatment of cancers, preparations for the treatment of urological diseases and disorders, preparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, hormone replacement therapy preparations; drug substances, namely, enzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; medicated skin care gels and mineral supplements; food supplements; radio frequency identification tagged pharmaceutical products, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents for the treatment of urinary urgency, breathing, saliva and secretion, gut motility, and heart rate, endocrinology, orthopedics, and urology; pharmaceuticals preparations, namely, a blood clotting aid and delivery system for human use; prefilled syringe containing injectable pharmaceuticals for manual injection for the treatment of pain management, infectious diseases, central nervous system disorders, namely, epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders |
| Goods and Services | Manufacture of pharmaceutical products to the order and specification of others; providing technical information in the field of pharmaceutical manufacturing |
| Goods and Services | Providing health insurance information about health insurance benefits to patients; financial administration of patient reimbursement programs for pharmaceuticals; financial administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient; financial assistance programs that provide pharmaceuticals to help patients with insufficient resources to get treatment at little or no cost to the patient. |
| Goods and Services | Providing medical information and medical information via a website on the subjects of pharmaceutical preparations and medicines, medical devices and techniques; providing medical information and online medical and healthcare information to healthcare professionals and patients; providing medical information via a website; providing medication counseling information, namely, advice and data on the subjects of pharmaceutical preparations and medicine; providing medical information on the subjects of aesthetic solutions to help patents feel better about their bodies. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 26, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 26, 2026 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 26, 2026 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 26, 2026 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 26, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 26, 2026 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Mallinckrodt Pharmaceuticals Ireland Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | IE |
| Event Date | Event Description |
| Thursday, February 26, 2026 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, February 26, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 26, 2026 | APPLICATION FILING RECEIPT MAILED |
| Friday, March 13, 2026 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, March 13, 2026 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, March 13, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, March 13, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, March 13, 2026 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, April 17, 2026 | ASSIGNED TO EXAMINER |
| Monday, April 20, 2026 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 21, 2026 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, June 2, 2026 | REFUSAL PROCESSED BY MPU |
| Tuesday, June 2, 2026 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, June 18, 2026 | REFUSAL PROCESSED BY IB |
| Thursday, June 25, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 25, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 25, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 29, 2026 | FINAL REFUSAL WRITTEN |
| Monday, June 29, 2026 | FINAL REFUSAL E-MAILED |
| Monday, June 29, 2026 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, July 14, 2026 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, July 14, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 14, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 20, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, July 20, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Monday, July 20, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Monday, July 20, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |